Early or Locally Advanced HER2-positive Breast Cancer Clinical Trials in Shanghai

A Phase III Study of KN026 in Combination With HB1801 ± Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast Cancer